Larvol Delta - Pharmingannounced-that-the-US-Food-and-Drug-Administration-FDA-has-accepted-its-supplemental-New-Drug-Application-sNDA-seeking-approval-for-lower-doses-of-Joenja-leniolisib-an-oral-selective-phosphoinositide-3kinase-delta-PI3K-inhibitor

rapcabtagene autoleucel (YTB323) - Novartis

http://clinicaltrials.gov/ct2/show/NCT05798117

Sep 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next